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Objective. Activation of innate immunity cells is inseparably linked to cardiac surgical operation. The aim of this study was to
assess the kinetics in the expression of receptor for Fc part of IgG, FcγRI (CD64), and scavenger receptor CD163 on peripheral
blood cells of cardiac surgical patients and to examine the eﬀect of cardiac bypass as a separable inﬂuence on the systemic acute
inﬂammatory response. Methods. Forty patients, twenty in each group, were randomly assigned to CABG surgery performed
either with “on-pump” or without “oﬀ-pump” cardiopulmonary bypass. Standardized quantitative ﬂow cytometry method was
used to determine the expression of surface markers. Results. The density of CD64 molecule on monocytes reached maximum
on the 1st postoperative day (P<. 001) whereas the peak for CD64 molecule expression on granulocytes was postponed to the
3rd postoperative day (P<. 001). The expression of CD163 scavenger molecule on monocytes reached maximum on the 1st
postoperative day (P<. 001). The density of CD163 molecule on monocytes on the 1st postoperative day is signiﬁcantly higher
in “on-pump” patients in comparison with “oﬀ-pump” patients (P<. 001). Conclusion. In cardiac surgical patients the expression
of activation marker FcγR1 (CD64) on monocytes is increased earlier in comparison with granulocytes in both “on-pump” and
“oﬀ-pump” patients. The expression of scavenger molecule CD163 on monocytes is signiﬁcantly higher in “on-pump” patients.
Copyright © 2008 Martina Kolackova et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Numerous events, potentially generating an inﬂammatory
response,areinducedduringcardiacsurgery.Amongstthem,
thecombinationofsurgicalinjury,mechanicalmanipulation
with the heart, the contact of blood components with the ar-
tiﬁcial surfaces of the cardiopulmonary bypass circuit, tran-
sient endotoxemia and ischemia-reperfusion injury of the
heart and lungs are relevant [1]. The inﬂammatory reaction
is the result of a complex interplay between numerous hu-
moral factors and cell substrate of inﬂammation. Amongst
cells involved in this process special role is devoted to in-
nate immunity monocyte-macrophages and granulocytes.
Whereas monocyte-macrophage cells are the richest source
of pluripotent proinﬂammatory cytokines upon activation,
activated granulocytes are recruited into tissues by stepwise
interaction between adhesion molecules on the surface of
leukocytes and their corresponding receptors expressed on
the lumenal surface of inﬂamed endothelium [2]. There is a
substantiallonglastingeﬀorttoidentifyactivatedmonocytes
andneutrophilsinbloodofpatientswithsystemicinﬂamma-
tory response induced by various stimuli either to identify
patients at the risk of development of overwhelming inﬂam-
matory response potentially ultimating into multiple organ
failure syndrome (MOFS) or to implicate the causative agent
of such inﬂammatory response, for example, bacterial infec-
tion [3].2 Mediators of Inﬂammation
Activation of myeloid cells by various physiological and
experimental stimuli is accompanied by multiple surface
changes associated predominantly with degranulation. Thus,
activated blood myeloid cells typically upregulate surface
expression of chemotactic receptors, complement receptor
type 3 (CD11b/CD18), and downmodulate surface density
of lipopolysacharide (LPS) receptor CD14, the low aﬃn-
ity FcγRIII or CD16 receptor, adhesion receptors CD44 and
CD62L [4].
The Fcγ-receptor I, FcγRI, (CD64), is a high aﬃnity re-
ceptor for IgG1 and IgG3 subclasses of immunoglobulins.
FcγRIisconstitutivelyexpressedwithhighdensityonmono-
cytes and macrophages, less so on eosinophils, but only to a
very low extent on resting neutrophils.
Numerous substances both exogenous and endogenous
origins rapidly upregulate FcγRI expression on the surface of
neutrophils [5] .M i c r o b i a lc e l lw a l lc o m p o n e n t ss u c ha sL P S ,
endogenous complement split products, and cytokines, such
asIFNγ andTNFα,aresomeoftheactivators.Theexpression
of FcγRI is determined by immunoﬂuorescence and ﬂow cy-
tometry. The introduction of a new diagnostic kit Leuko64
enables standardized and quantitative approach to the deter-
mination of FcγRI expression on immune cells.
Hemoglobin scavenger receptor CD163 is a group B
cysteine-richscavengerreceptorexpressedexclusivelybycells
of monocyte-macrophage lineage. This glycoprotein is char-
acterized as a scavenger receptor for hemoglobin, mediating
endocytosis of hemoglobin-haptoglobin complexes. Previ-
ous studies have indirectly linked CD163 scavenger receptor
to anti-inﬂammatory phenomena [6]. High CD163 expres-
sion correlates with the Mo2 anti-inﬂammatory properties
of monocytes and macrophages [7].
The aim of this study was to follow the changes in the ex-
pression of granulocyte activation markers FcγRI and anti-
inﬂammatory CD163 scavenger receptor in patients under-
going cardiac surgical operation either with the use of car-
diopulmonary bypass (“on-pump”) or operated on the beat-
ing heart during “oﬀ-pump” operation and in the postoper-
ative period using quantitative ﬂow cytometric approach.
2. PATIENTS
Forty patients (31 males, mean age 67.9 ± 9a n d9f e -
males, mean age 66.4 ± 6.4, collective mean age 67.6 ± 8.5
years) referred to ﬁrst-time coronary artery bypass graft-
ing (CABG) were enrolled in this study. Patients underwent
either conventional myocardial revascularization with car-
diopulmonary bypass and cardioplegic arrest of the heart
(“on-pump,” n = 20, 16 males, 4 females, mean age 69.4 ±7)
or beating heart surgery (“oﬀ-pump,” n =20, 15 males, 5 fe-
males, mean age 65.9 ± 9.7).
Patients in both groups were comparable in age, preop-
erative left ventricular ejection fraction (median 0.65 in “on-
pump,” 0.65 in “oﬀ-pump” patients, resp.) and the num-
ber of performed coronary anastomoses (median 2.0 in “on-
pump,” 2.0 in “oﬀ-pump,” resp.). The study protocol was ap-
proved by the Ethics Committee of the University Hospital
in Hradec Kr´ alov´ e. All participants were informed in detail
about the purpose of the study both orally and in writing.
They were free to ask any questions. One person refused to
participate for reasons he would not specify. All active sub-
jects have given written informed consents.
Cardiopulmonary bypass, “oﬀ-pump” technique, and
anesthesiological management have been recently described
in detail elsewhere [8].
3. BLOOD SAMPLING
Peripheral venous blood from an antebrachial vein was with-
drawn in the operating room and in the intensive care unit.
Samples were collected into heparinized tubes Vacutainer,
Cat. no. 36884 manufactured by Becton Dickinson.
In both “on-pump” and “oﬀ-pump” patients, blood was
withdrawn at the following time points:
(1) introductiontoanaesthesia,whichinbothgroupsrep-
resented the baseline or reference value for all param-
eters measured thereafter,
(2) after termination of the operation,
(3) the ﬁrst postoperative day,
(4) the third postoperative day,
(5) the seventh postoperative day.
Additional samples were taken from “on-pump” patients:
(1a) before cross-clamping of the aorta,
(1b) after aortic cross-clamp release,
(1c) after termination of CPB.
4. MATERIALS AND METHODS
Leuko64 kit manufactured by Trillium Diagnostics, LLC,
(www.trilliumdx.com,B r e w e r ,M e ,U S A )w a su s e dt od e t e r -
mine the expressions of CD64 and CD163 on leukocytes of
blood samples. Leuko64 kit is composed of a reagent cock-
tail of two monoclonal antibodies with speciﬁties to CD64
(clones 22 and 32.2, both FITC conjugated) and monoclonal
antibody to CD163 (clone Mac2-148, phycoerythrin conju-
gated) and a ﬂuorescence beads suspension used for instru-
ment calibration and standardization of leukocyte CD64 and
CD163 expressions in human blood. The assay was run ac-
cording to the instruction for use provided by manufacturer.
Brieﬂy, 50 microliters of blood and the Leuko64 monoclonal
cocktail reagent are incubated for 10 minutes, red cell lysis
buﬀer is added and incubated for additional 15 minutes, and
5 microliters of bead suspension are added prior to ﬂow cy-
tometric analysis. Results were measured by an FACSCalibur
ﬂow cytometer (BD Biosciences, San Jose, Calif, USA) using
CELLQuest software. The listmode data were analyzed us-
ing Leuko64 software (Trillium Diag.). Results are expressed
as indexes of positivity for CD64 and CD163 expressions on
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Figure 1: CD64 molecule expression on monocytes in “on-pump”
and “oﬀ-pump” patients.
anesthesia were considered as reference or baseline expres-
sionsofCD64andCD163.Diﬀerencesbetween“oﬀ-andon-
pump” patients were also evaluated.
Data were analyzed using two-way ANOVA for repeated
measures with Fisher test for multiple comparisons. To ex-
clude confounding eﬀect of diﬀerent age and sex presenta-
tion in both groups, unpaired t-test and chi-square were per-
formed. A probability (P)v a l u e< .05 was considered signif-
icant. Statistical analysis was performed with Statistica 5.5
software (Statsoft, Okla, USA).
6. RESULTS
We found substantial dynamics in the expressions of both
CD64 and CD163 molecules on immune cells in our car-
diacsurgicalpatients.Thesechangesareexpressedaschanges
in CD64 and CD163 indexes separately for monocytes and
granulocytes. Preoperative levels were taken as reference
points. There were no signiﬁcant changes in the monocyte
CD64expressionduringcardiacoperationin“on-pump”pa-
tients (data not shown). Themonocytes CD64 index wassig-
niﬁcantly increased in both “on-pump” and “oﬀ-pump” pa-
tients in postoperative period from the ﬁrst to the seventh
day (P < .01). Comparing monocyte CD64 index between
“on-pump” and “oﬀ-pump” patients, there were no signiﬁ-
cant diﬀerences (P < .587) during operation and in the post-
operative period (Figure 1). The similar patterns were found
for monocyte CD163 index in our cardiac surgical patients
with following exceptions. Monocyte CD163 index, in con-
trast to the monocyte CD64 index showed a signiﬁcant dif-
ference as a function of the pump status. There was a statis-






































































































































































































































































































Figure 3: CD64 molecule expression on granulocytes in “on-
pump” and “oﬀ-pump” patients.
pump” patients compared to “oﬀ-pump” patients at the ﬁrst
postoperative day (P < .001) (Figure 2). The signiﬁcant in-
crease in monocyte CD163 index in both “on-pump” and
“oﬀ-pump”patientscomparedtothebaselineexpressionwas
found only at the 1st and 3rd postoperative days (P < .01).
The granulocyte CD64 index was signiﬁcantly increased
both in “on-pump” and “oﬀ-pump” patients at the 1st and4 Mediators of Inﬂammation
3rd postoperative days. Statistically signiﬁcant diﬀerences of
granulocyte CD64 indexes between “on-pump” and “oﬀ-
pump” were not reached (P < .195) (Figure 3). The origi-
nal and pathophysiologically very important observation in
our results is that the maximum of CD64 expression on
monocytes (1st postoperative day) precedes the maximum
of CD64 expression on granulocytes (3rd postoperative day).
The granulocyte CD64 expression returned to baseline or
normal levels by the 7th postoperative day.
7. DISCUSSION
A long-term sustained eﬀort is devoted to the better un-
derstanding of inﬂammatory reaction which is inseparably
linked to every cardiac surgical operation. Numerous hu-
moral and cell-mediated parameters of immune system have
been studied to identify markers describing the development
of such inﬂammatory reaction. The ultimate goal of such
studies is to identify those patients who are at substantial
risk for development of overwhelming systemic inﬂamma-
tion (SIRS), a condition of complex physiology that might
severely compromise the outcome of surgery or even lead
to death. Many studies conducted in the last few years have
shown reduced inﬂammation in patients operated on by
the “oﬀ-pump” technique compared to “on-pump” surgery
[9]. On the other hand, any deﬁnitive proof in favor of
“oﬀ-pump” surgery in terms of reduced long-term mortal-
ity compared to its “on-pump” counterpart has not been re-
ported.Theverytraumaofsurgeryseemstobemorerelevant
in initiating SIRS rather than cardiopulmonary bypass itself,
the latter adding a CPB speciﬁc fraction on top of unfavor-
able events [10].
The objective of this study was to compare the degree of
activation of innate immunity cells between “on-pump” and
“oﬀ-pump” patients. The novel diagnostic Leuko64 kit was
used by us to dissect such diﬀerences. This kit enables quan-
titative determination of CD64/CD163 molecule expression
on immune cells by ﬂow cytometry.
FcγR1 receptor (CD64) is constitutively expressed on
macrophages, monocytes, and eosinophils, but its expres-
sion is negligible on resting neutrophils. Neutrophil CD64
molecule expression is one of many activation-related sur-
face receptors changes manifested during the normal innate
immunity response. Microbial cell wall components such
as LPS, complement split products, and cytokines (IFNγ,
TNFα) are some of the activators [3]. In contrast to nu-
merous other neutrophilic activation surface antigens, such
as CD11b/CD18, CD14, and CD16 with large storage intra-
cellular pools, CD64 has limited intracellular storage, but de
novo synthesis can be induced in the presence of proinﬂam-
matory conditions. In comparison with former neutrophilic
activation markers, CD64 expression on neutrophils is thus
much less aﬀected by stimuli of degranulation to which these
cells are extensively exposed both during cardiac surgical op-
eration and during blood sample processing [5]. Thus CD64
molecule appears uniquely suited as a surrogate marker of
neutrophil activation or systemic acute inﬂammatory re-
sponse as its expression starts from less than 2000 sites per
cell and becomes upregulated in a graded fashion depending
upon intensity of stimulation by cytokines [4].
Clinical usefulness of CD64 determination has been
proven in diﬀerential diagnosis of sepsis of bacterial origin.
Changes in the expression of CD64 on circulating leukocytes
in patients undergoing cardiothoracic surgery were also re-
ported [11]. Some of these previous works are suﬀering from
the lack of precise quantitation since CD64 positivity was for
example expressed as mean ﬂuorescence intensity [11, 12].
This means of quantitation is valid on a single platform for
day to day comparison, but lacks standardization necessary
for a routine clinical laboratory test, whereas the Leuko64 kit
approach does allow for interlaboratory comparisons. Ap-
plication of a new standardized diagnostic kit in our study
overcomes above mentioned limitations. Using calibration
ﬂuorescence beads and specialized software, CD64/CD163
density is expressed as index positivity separately for gran-
ulocytes and monocytes. As expected, CD64 positivity on
monocytes is one log higher in comparison with granulo-
cytes. A signiﬁcant increase in both monocytes and gran-
ulocytes CD64 expressions has been found on the 1st and
3rd postoperative days. No signiﬁcant diﬀerences between
“on-pump” and “oﬀ-pump” patients have been recognized.
Whereas CD64 expression on monocytes is nearly identical
for both “on-pump” and “oﬀ-pump” patients, there is a ten-
dency for higher granulocyte CD64 index on the 3rd post-
operative day in “on-pump” patients. This likely reﬂects the
greater sensitivity to cytokine eﬀects of granulocytes com-
pared to monocytes. Our results are in contrast to the work
of Stefanou et al. [13] who did not report any induction of
CD64 expression on monocytes of cardiac surgical patients
post CPB. However, only 10 patients were enrolled to their
study with some diﬀerences in CPB compared to our pa-
tients. Furthermore, our attempt using Leuko64 kit ensures
better standardisation of method in comparison with previ-
ous work, where positivity was expressed as a simple MFI.
The neutrophils CD64 index is designed so that normal
inactivated cells yield value of <1.00 and blood samples from
individuals with documented sepsis or SIRS typically show
values of >1.50. In our patients, the perioperative and post-
operative period was uneventfull with the only one excep-
tion, the patient, who will be discussed below. It is our orig-
inal observation that the maximum of CD64 expression on
monocytes of our cardiac surgical patients has already been
reached on the 1st postoperative day in contrast to granulo-
cytes in which the maximum of CD64 expression has been
postponed to the 3rd postoperative day. This observation
implies that FcγRI expression on monocytes is upregulated
by a diﬀerent cellular mechanism very early during opera-
tion by the exposition of monocytes to various danger pat-
terns which are raised during operation. The upregulation
of FcγRI on granulocytes is a secondary event mediated by
their exposition to proinﬂammatory cytokines and media-
tors formed by monocytes-macrophages.
The FcγRI receptor (CD64) on white blood cells inte-
grate responses involving both the innate and acquired im-
mune systems and are very important for eﬀective phago-
cytosis of bacteria and immune complexes. A new, intrinsic
role for this receptor has recently been proposed by DevarajMartina Kolackova et al. 5
et al. who have described the participation of FcγR on in-
ternalization of C-reactive protein by endothelial cells, with
subsequent release of chemoattractive proinﬂammatory IL-
8, decrease of eNOS, and increased ICAM-1 and VCAM-1
adhesion molecules [14]. In conclusion, FcγRI reveals proin-
ﬂammatory activities in general.
Proinﬂammatorypathwayshavetobetightlycounterbal-
ancedbynumerousanti-inﬂammatoryprocesses,thatispro-
duction of anti-inﬂammatory cytokines such as IL-10 [15],
to maintain protective physiological level of inﬂammatory
response in cardiac surgical patients. Another approach to
calm down inﬂammatory reaction is removing of pleiotropic
proinﬂammatory species by the action of so-called scavenger
receptors which are diﬀerentially expressed on cells of both
immune and nonimmune origins [6]. Unique characteristics
amongst these scavenger receptors reveal hemoglobin scav-
enger receptor (CD163). CD163 scavenger receptors repre-
sent a highly eﬃcient system to remove potentially toxic and
proinﬂammatory hemoglobin from the circulation and local
sitesofinﬂammation[16].Cardiacsurgicalpatientareexten-
sively exposed to large amounts of free heme/hemeproteins
due to intravascular haemolysis and tissue damage. There
is accumulating evidence that an excess of free heme can
cause cell damage and tissue injury. Heme catalyzes the for-
mation of reactive oxygen species (ROS), resulting in oxida-
tive stress. Because the low-molecular weight iron chelated
heme is lipophilic, it can easily intercalate in the membrane
and impair lipid bilayers and organelles, such as mitochon-
dria and nuclei, and destabilize cytoskeleton [17]. Several
defense mechanisms against free heme-mediated oxidative
stress and inﬂammation exist. They consist of intra- (e.g.,
heme oxygenase-2 and heme oxygenase-3) and extracellu-
lar (e.g., hemopexin, albumin) scavengers, antioxidative en-
zymes, and heme oxygenase-1 during hemolysis.
Intravascular free hemoglobin is captured by plasma
scavenger protein haptoglobin. It is generally accepted
that stable hemoglobin-haptoglobin complexes are subse-
quentlydeliveredtothereticuloendothelialsystembyCD163
receptor-mediated endocytosis [16]. Any free vascular heme
is bound to the plasma protein hemopexin or albumin,
which transport it to the liver for degradation in reticuloen-
dothelial system. However, when large amounts of free heme
proteins or heme (locally) accumulate, like in a blood clot or
after vascular deposition, the scavengers get overwhelmed or
areunabletoreachthem.Thisenableshemetoexertitsdam-
aging eﬀects. Therefore, the amount of free heme must be
tightly controlled to maintain homeostasis and avoid patho-
logical conditions.
The monocyte CD163 index has been found to be be-
tween 5000 and even 40000 in our study. There was a sharp
increase of monocyte CD163 in the postoperative period
reaching statistically highly signiﬁcant maximum (P < .001)
on the 1st postoperative day for both “on-pump” and “oﬀ-
pump” patients followed by decrease to the baseline preop-
erative levels. Furthermore, the patients’ monocyte CD163
index is signiﬁcantly higher (P < .001) in “on-pump” pa-
tient group on the 1st postoperative day. Reports regarding
monocyte CD163 expression in cardiac surgical patients are
very sparse. In a study by Goldstein et al. [18], a signiﬁcant
increase in the monocyte CD163 expression on the 1st post-
operative day was found. This is in accord with results of our
study. But there were several limitations in a previous study.
CD163 molecule was expressed as mean ﬂuorescence index
(MFI) in comparison with our study in which standardized
quantitative approach using calibration ﬂuorescence beads
was exploited yielded much more relevant data. The changes
in the entire perioperative period and during postoperative
period up to the 7th postoperative day have been followed by
us in comparison with a previous study.
The link of CD163 hemoglobin scavenger receptor to
anti-inﬂammatory phenomena in cardiac surgical patients
has been proven by Philippidis et al. [19]. In their study, ele-
vated expression of CD163 on circulating monocytes during
the resolution phase of the systemic inﬂammatory response
to cardiopulmonary bypass surgery was reported. Further-
more, binding of hemoglobin-haptoglobin complexes to
CD163 expressing monocytes elicited potent interleukin-10
secretion. It was reported by Goldstein et al. [18] that an
increase in the monocyte CD163 expression was 14 times
higher in their “on-pump” patients who were treated by bo-
lus administration of metylprednisolone perioperatively in
comparison with untreated patients. Such therapeutical in-
tervention was not performed in any our patients. It seems
unlikely that higher monocyte CD163 expression in our “on-
pump” patients was elicited by metylprednisolone which is a
regular component of CPB ﬂuids used at our department.
More pronounced proinﬂammatory stimuli raised during
“on-pump” surgery are more relevant. There will be the
unique chance to dissect between the inﬂuence of corticos-
teroids present in CPB ﬂuid and other variables involved
in “on-pump” surgery. Currently, CPB protocol used at our
department has been changed and methylprednisolone has
been ommited. CD163 is rapidly shed from the surface of
monocytes when activated by LPS or phorbol esters. In
addition, also cross-linking of FcγR triggers shedding of
CD163 [20]. This phenomenon is very likely counterbal-
anced by the fact that such shedding is followed by upreg-
ulation of this hemoglobin scavenger receptor, as was shown
for metaloproteinases-mediated CD163 shedding [21]. This
is probably true for our cardiac surgical patients. Very re-
cently, it was proven by Weaver et al. [22] that CD163 shed-
ding is also induced via stimulation with TLR-4, TLR-2, and
TLR-5.
Initially included in this study was a single patient, male,
73 years old who was excluded from our study due to his
death on the 2nd postoperative day. This patient underwent
uncomplicated cardiac surgery using cardiopulmonary by-
pass. He developed acute diaphragmatic myocardial infarc-
tion two hours after ﬁnishing surgery. Patient was reoperated
and reanastomosis was performed. In spite of this eﬀort, car-
diogenic and subsequent hemorrhagic shock was developed
ultimating to death next day in the morning. Body tempera-
ture was below 36
◦C so that infection is unlikely.
The expression of both CD64 and CD163 molecules be-
fore surgery and up to the end of surgery was comparable
with other patients. Granulocyte CD64 index reached 1.72
value which is signiﬁcant for the development of SIRS [23].
However, such values were found in additional four patients6 Mediators of Inﬂammation
without any impact on their postoperative course. Remark-
able is the fact that monocyte CD163 index in this patient
was the highest between our patients and was approximately
two times higher in comparison with all our patients investi-
gated. It could be concluded from this our anecdotal obser-
vation that the increase in CD163 monocyte positivity could
be the marker with predictive value of worse outcome in car-
diac surgical patients.
In conclusion, using standardized quantitative methods
we revealed substantial dynamics in the expression of the
activation marker FcγRI and scavenger receptor CD163 in
both “on-pump” and “oﬀ-pump” cardiac surgical patients
during operation and in the postoperative period. The max-
imum in the expression of CD64 on monocytes in postoper-
ative period precedes the maximum in the expression of this
molecule on granulocytes by two days.
ACKNOWLEDGMENT
This work has been supported by a research program of The
Czech Ministry of Youth, School and Physical Activities no.
MSM 0021620812 and Internal Grant Agency of Ministry of
Health, Czech Republic, no. NR/9090-4.
REFERENCES
[ 1 ]R .A s c i o n e ,C .T .L l o y d ,M .J .U n d e r w o o d ,A .A .L o t t o ,A .A .
Pitsis, and G. D. Angelini, “Inﬂammatory response after coro-
nary revascularization with or without cardiopulmonary by-
pass,” The Annals of Thoracic Surgery, vol. 69, no. 4, pp. 1198–
1204, 2000.
[2] D. A. Steeber, G. M. Venturi, and T. F. Tedder, “A new twist to
the leukocyte adhesion cascade: intimate cooperation is key,”
Trends in Immunology, vol. 26, no. 1, pp. 9–12, 2005.
[ 3 ]A .C .B a k k e ,E .A l l e n ,M .Z .P u r t z e r ,a n dA .D e o d h a r ,“ N e u -
trophil CD64 expression distinguishing acute inﬂammatory
autoimmune disease from systemic infections,” Clinical and
Applied Immunology Reviews, vol. 1, no. 5, pp. 267–275, 2001.
[4] M.T.ElghetanyandB.H.Davis,“Impactofpreanalyticalvari-
ables on granulocytic surface antigen expression: a review,”
Cytometry Part B: Clinical Cytometry, vol. 65, no. 1, pp. 1–5,
2005.
[ 5 ] S .S .Q u r e s h i ,S .M .L e wi s ,V .A .G a n t ,D .T r e a c h e r ,B .H .D a vi s ,
and K. A. Brown, “Increased distribution and expression of
CD64 on blood polymorphonuclear cells from patients with
the systemic inﬂammatory response syndrome (SIRS),” Clini-
cal & Experimental Immunology, vol. 125, no. 2, pp. 258–265,
2001.
[6] D. R. Greaves and S. Gordon, “Recent insights into the biology
of macrophage scavenger receptors,” Journal of Lipid Research,
vol. 46, no. 1, pp. 11–20, 2005.
[7] W.Xu,N.Schlagwein,A.Roos,T.K.vandenBerg,M.R.Daha,
and C. van Kooten, “Human peritoneal macrophages show
functionalcharacteristicsofM-CSF-drivenanti-inﬂammatory
type2macrophages,”EuropeanJournalofImmunology,vol.37,
no. 6, pp. 1594–1599, 2007.
[8] P. Kunes, V. Lonsky, J. Mandak, et al., “The long pentraxin 3
in cardiac surgery: distinct responses in “on-pump” and “oﬀ-
pump”patients,”ScandinavianCardiovascularJournal,vol.41,
no. 3, pp. 171–179, 2007.
[9] D. Paparella, T. M. Yau, and E. Young, “Cardiopulmonary by-
pass induced inﬂammation: pathophysiology and treatment.
An update,” European Journal of Cardio-Thoracic Surgery,
vol. 21, no. 2, pp. 232–244, 2002.
[10] M. Rossi, G. Sganga, M. Mazzone, et al., “Cardiopulmonary
bypass in man: role of the intestine in a self-limiting inﬂam-
matory response with demonstrable bacterial translocation,”
The Annals of Thoracic Surgery, vol. 77, no. 2, pp. 612–618,
2004.
[11] M. J. Hiesmayr, A. Spittler, A. Lassnigg, et al., “Alterations in
the number of circulating leucocytes, phenotype of monocyte
and cytokine production in patients undergoing cardiotho-
racic surgery,” Clinical & Experimental Immunology, vol. 115,
no. 2, pp. 315–323, 1999.
[12] G.Fjaertoft,L.Hakansson,T.Foucard,U.Ewald,andP.Venge,
“CD64 (Fcγ receptor I) cell surface expression on maturing
neutrophils from preterm and term newborn infants,” Acta
Paediatrica, vol. 94, no. 3, pp. 295–302, 2005.
[13] D.C.Stefanou,G.Asimakopoulos,D.R.Yagnik,etal.,“Mono-
cyte Fc gamma receptor expression in patients undergo-
ing coronary artery bypass grafting,” The Annals of Thoracic
Surgery, vol. 77, no. 3, pp. 951–955, 2004.
[14] S. Devaraj, T. W. Du Clos, and I. Jialal, “Binding and inter-
nalization of C-reactive protein by Fcgamma receptors on hu-
man aortic endothelial cells mediates biological eﬀects,” Arte-
riosclerosis,Thrombosis,andVascularBiology,v ol.25,no .7,pp .
1359–1363, 2005.
[15] C. P. Schneider, M. G. Schwacha, and I. H. Chaudry, “The role
of interleukin-10 in the regulation of the systemic inﬂamma-
tory response following trauma-hemorrhage,” Biochimica et
Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1689,
no. 1, pp. 22–32, 2004.
[16] J. Zuwała-Jagiełło, “Haemoglobin scavenger receptor: func-
tion in relation to disease,” Acta Biochimica Polonica, vol. 53,
no. 2, pp. 257–268, 2006.
[17] F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, et al., “Diﬀerent
faces of the heme-heme oxygenase system in inﬂammation,”
Pharmacological Reviews, vol. 55, no. 3, pp. 551–571, 2003.
[18] J. I. Goldstein, K. A. Goldstein, K. Wardwell, et al., “Increase
in plasma and surface CD163 levels in patients undergoing
coronary artery bypass graft surgery,” Atherosclerosis, vol. 170,
no. 2, pp. 325–332, 2003.
[19] P. Philippidis, J. C. Mason, B. J. Evans, et al., “Hemoglobin
scavenger receptor CD163 mediates interleukin-10 release and
heme oxygenase-1 synthesis: antiinﬂammatory monocyte-
macrophage responses in vitro, in resolving skin blisters in
vivo, and after cardiopulmonary bypass surgery,” Circulation
Research, vol. 94, no. 1, pp. 119–126, 2004.
[20] T. H. Sulahian, P. A. Pioli, K. Wardwell, and P. M. Guyre,
“Cross-linking of FcγR triggers shedding of the hemoglobin-
haptoglobin scavenger receptor CD163,” Journal of Leukocyte
Biology, vol. 76, pp. 271–277, 2004.
[21] K. A. Hintz, A. J. Rassias, K. Wardwell, et al., “Endotoxin in-
ducesrapidmetalloproteinase-mediatedsheddingfollowedby
up-regulation of the monocyte hemoglobin scavenger recep-
tor CD163,” Journal of Leukocyte Biology,v o l .7 2 ,n o .4 ,p p .
711–717, 2002.
[22] L. K. Weaver, K.A. Hintz-Goldstein, P. A. Pioli, et al., “Pivotal
advance: activation of cell surface Toll-like receptors causes
shedding of the hemoglobin scavenger receptor CD163,” Jour-
nal of Leukocyte Biology, vol. 80, no. 1, pp. 26–35, 2006.
[23] B. H. Davis, S. H. Olsen, E. Ahmad, and N. C. Bigelow, “Neu-
trophil CD64 is an improved indicator of infection or sepsis
in emergency department patients,” Archives of Pathology and
Laboratory Medicine, vol. 130, no. 5, pp. 654–661, 2006.